SAS and Carolina partner to accelerate antiviral drug development

Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI). (UNC.edu)

Related: Campus Connections

Tar Heels Top Their Best Multi-Year Graduation Success Rate For Fifth Straight Year
UNC student-athletes established their highest multi-year graduation rates for the fifth straight year and set the record for the best single-year rate as reported in...
Thu Nov 21, 2024

Clouds Brewing opens new location on Franklin Street, replacing Gizmo Brew Works
Clouds Brewing, a Triangle-based brewery, opened a third location on Franklin Street, replacing the space previously occupied by Gizmo Brew Works. On August 14, Gizmo...
Wed Nov 20, 2024

20 Years of the Carolina Covenant
Established in 2004, the Carolina Covenant is a financial aid package and network of support that provides an opportunity for students to graduate from the...
Sun Nov 17, 2024

10 things every UNC fan must do when visiting Chapel Hill
Locals call it Blue Heaven and it doesn’t take long to understand why. Virtually everything in town is painted the color of the sky. Even...
Fri Nov 15, 2024